Takeda Pharma A/S
SpainAll drugs from this manufacturer
-
It is used to treat three types of white blood cell cancers: classical Hodgkin lymphoma, systemic anaplastic large cell lymphoma, and cutaneous T-cell lymphoma.
Dosage form: powder for concentrate for solution for infusion
Active substance Dosage brentuximab vedotin 50 mg -
It is used to treat a type of lung cancer in adults at advanced stages (non-small cell lung cancer) that presents an abnormal form of a gene called ALK.
Dosage form: tablets, film-coated
Active substance Dosage brigatinib 180 mg -
It is used to treat a type of lung cancer in adults in advanced stages called non-small cell lung cancer, provided that the cancer is related to an abnormal form of a gene called ALK.
Dosage form: tablets, film-coated
Active substance Dosage brigatinib 30 mg -
It is used to treat a type of lung cancer in adults at advanced stages (non-small cell lung cancer) that is related to an abnormal form of a gene called ALK.
Dosage form: tablets, film-coated
Active substance Dosage brigatinib 90 mg brigatinib 180 mg -
It is used to treat a type of lung cancer in adults in advanced stages (non-small cell lung cancer) that is related to an abnormal form of a gene called ALK.
Dosage form: tablets, film-coated
Active substance Dosage brigatinib 90 mg -
It is used to treat the signs and symptoms of moderate to severe active ulcerative colitis and moderate to severe active Crohn's disease in adults.
Dosage form: solution for injection in pre-filled pen
Active substance Dosage vedolizumab 108 mg -
It is used to treat signs and symptoms in adults with moderate to severe active ulcerative colitis, moderate to severe active Crohn's disease, and moderate to severe active chronic diverticulitis.
Dosage form: powder for concentrate for solution for infusion
Active substance Dosage vedolizumab 300 mg -
It is used to reduce blood sugar levels in adults with type 2 diabetes when diet, exercise, and other medications are not sufficient to control it.
Dosage form: tablets, film-coated
Active substance Dosage alogliptin 12,5 mg pioglitazone 30 mg -
It is used to reduce blood sugar levels in adults with type 2 diabetes when diet, exercise, and other medications are not sufficient to control it.
Dosage form: tablets, film-coated
Active substance Dosage alogliptin 25 mg pioglitazone 30 mg -
It is used to reduce blood sugar levels in adults with type 2 diabetes when diet, exercise, and other medications are not sufficient to control it.
Dosage form: tablets, film-coated
Active substance Dosage alogliptin 12,5 mg metformin hydrochloride 1000 mg -
It is used to reduce blood sugar levels in adults with type 2 diabetes when it cannot be controlled through diet, exercise, or other medications.
Dosage form: tablets, film-coated
Active substance Dosage alogliptin 12,5 mg metformin hydrochloride 1000 mg -
It is used to reduce blood sugar levels in adults with type 2 diabetes when diet, exercise, and other medications are not sufficient to control it.
Dosage form: tablets, film-coated
Active substance Dosage alogliptin 12,5 mg metformin hydrochloride 850 mg -
It is used to reduce blood sugar levels in adults with type 2 diabetes when it cannot be controlled by diet, exercise, and other medications alone.
Dosage form: tablets, film-coated
Active substance Dosage alogliptin 12,5 mg metformin hydrochloride 850 mg -
It is used to reduce blood sugar levels in adults with type 2 diabetes when diet and exercise are not enough to control it.
Dosage form: tablets, film-coated
Active substance Dosage alogliptin 12,5 mg -
It is used to reduce blood sugar levels in adults with type 2 diabetes when diet and exercise are not sufficient to control it.
Dosage form: tablets, film-coated
Active substance Dosage alogliptin 25 mg -
It is used to reduce blood sugar levels in adults with type 2 diabetes when diet and exercise are not enough to control it.
Dosage form: tablets, film-coated
Active substance Dosage alogliptin 6,25 mg